Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02115620 · ClinicalTrials.gov registry record · NA
Telemedicine Technology Demonstration Project for Heart Failure
A NA study, sponsored by Providence Health & Services.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02115620 is a NA study that has completed, run by Providence Health & Services. The registered enrollment target is 12 participants.
The verdict
NCT02115620, a NA study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to see if telemedicine can help improve the health of patients with heart failure who have recently been hospitalized with heart problems, and are being discharged to a Skilled Nursing Facility. Telemedicine uses electronic communications to make patient/doctor visits possible from a distance. This study will use remote video to allow heart failure specialists at Providence St. Vincent Medical Center to provide clinical health care to patients at Marquis Hills. Electronic monitors (including an electronic scale and blood pressure machine), and phone calls with the Marquis Hill nursing staff will be used to track patients' health status. The nursing staff will provide the heart failure specialists with daily updates on patients' symptoms, weight, vital signs (heart rate, blood pressure, pulse), and results of blood tests. Additionally, some patients will be provided with monitoring devices that include an iPhone blood pressure monitor, and Smart Body Analyzer to use for 14 days. The Smart Body Analyzer measures weight, body fat percentage, and heart rate. It also measures indoor air quality. Special software on the iPhone will save this information and the information will be transmitted by secure email to the study doctors. Hypothesis: The patients followed by telemedicine will have fewer visits to the Emergency Department, fewer deaths, and fewer hospital re-admissions than last year's site-specific average for this patient population.
Interventions
- OTHER Telemedicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-03-23 |
| Est. Completion | 2015-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02115620
The ClinicalTrials.gov registry entry for NCT02115620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telemedicine is the first listed.
NCT02115620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02115620 about?
NCT02115620 is a clinical study titled "Telemedicine Technology Demonstration Project for Heart Failure". The purpose of this study is to see if telemedicine can help improve the health of patients with heart failure who have recently been hospitalized with heart problems, and are being discharged to a Skilled Nursing Facility. Telemedicine uses electronic communications to make patient/doctor visits po...
What is the current status of trial NCT02115620?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-03-23. Estimated completion is 2015-08-26.
What interventions are being tested in trial NCT02115620?
The interventions under investigation include: Telemedicine (OTHER).
Who is sponsoring clinical trial NCT02115620?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.